Characterized by telangiectasias, sebaceous hyperplasia, and erythematous hypertrophied skin of the nose, rhinophyma is a deforming and debilitating condition. The term rhinophyma appropriately originates from the Greek rhis and phyma, meaning nose and growth.

First described in 1845 by Hebra, this condition is now understood as the final stage of acne rosacea. In 1851, von Langenbeck recognized the potential for treatment with partial excision and spontaneous re-epithelialization. Nevertheless, early treatment methods, up to the 1970s, often involved aggressive resection, which would lead to scarring or otherwise would require a reconstruction with skin grafts or even forehead flaps.

More recent treatment algorithms emphasize early medical management and the use of multiple treatment modalities for operative candidates. The senior author (R.J.R.) combines these multiple modalities in 5 steps to achieve safe, effective, and consistent results in the modern treatment of rhinophyma.

To read full article: bit.ly/35bnoDf

doi: 10.1097/GOX.0000000000002620